What Is TULSA?

March 24, 2026 - 05:02

A new, minimally invasive treatment for prostate cancer is now available, providing an alternative for men diagnosed with intermediate-risk cases. The procedure, known as transurethral ultrasound ablation (TULSA), uses precisely targeted sound waves to destroy cancerous tissue.

TULSA works by inserting a small ultrasound device into the urethra. From this position, it delivers controlled heat to the prostate, ablating the defined area of cancer while aiming to spare surrounding healthy structures. This approach is designed to reduce common side effects associated with more traditional prostate cancer therapies.

The outpatient procedure is MRI-guided, allowing for real-time imaging and temperature monitoring during treatment. This technology enables physicians to tailor the ablation zone specifically to the shape and size of the patient's tumor. Clinical studies suggest the treatment can effectively control cancer while preserving urinary and sexual function for many patients.

For eligible individuals, this represents a significant advancement in personalized cancer care. It offers a potential middle ground between active surveillance and more radical treatments, focusing on destroying the disease with a goal of maintaining quality of life. Physicians emphasize that patient selection is crucial, and a thorough consultation is necessary to determine if this innovative therapy is the appropriate course of action.